2022
DOI: 10.1099/acmi.0.000230
|View full text |Cite
|
Sign up to set email alerts
|

Intrathecal daptomycin use in a challenging case of Enterococcus faecium ventriculitis

Abstract: Treatment of ventriculitis caused by enterococci can be challenging, and antibiotic options are limited. We describe a case of device-related ventriculitis caused by vancomycin-resistant Enterococcus faecium , refractory to initial antibiotics. Our management approach included intrathecal daptomycin. There were no attributable adverse events, and the patient remained infection-free following ventriculo-peritoneal shunt inser… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…After systemic administration, daptomycin penetrates poorly into the CSF compartment, due to its low lipophilicity, significant protein binding and large molecular weight, thus resulting in insufficient concentrations to treat intracerebral infections [ 52 , 121 ]. In total, eight cases have been described in the literature with IT administration of daptomycin in the treatment of intracerebral infections due to Enterococci or Staphylococci (see Table 4 ) [ 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 ]. The IT doses administered ranged from 2.5 mg to 10 mg per dose, with the dosing frequency ranging from once per day to once per 72 h. The dose of 5 mg was used most frequently.…”
Section: Resultsmentioning
confidence: 99%
“…After systemic administration, daptomycin penetrates poorly into the CSF compartment, due to its low lipophilicity, significant protein binding and large molecular weight, thus resulting in insufficient concentrations to treat intracerebral infections [ 52 , 121 ]. In total, eight cases have been described in the literature with IT administration of daptomycin in the treatment of intracerebral infections due to Enterococci or Staphylococci (see Table 4 ) [ 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 ]. The IT doses administered ranged from 2.5 mg to 10 mg per dose, with the dosing frequency ranging from once per day to once per 72 h. The dose of 5 mg was used most frequently.…”
Section: Resultsmentioning
confidence: 99%